29,056 resources
By Version
By Authority
By Realm
Start Prev Rows 3200 - 3400 Next
Package | Version | Identity | Name/Title | Status | FMM | WG | Date | Realm | Auth | Source(s) |
---|---|---|---|---|---|---|---|---|---|---|
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1146.664 | Congenital Zika Syndromes (SNOMED) | active | 2024-01 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1146.665 | Congenital Zika Syndromes (ICD10CM) | active | 2023-01 | us | hl7 | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1146.666 | Guillain Barré syndrome (Disorders) (SNOMED) | active | 2024-06 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1146.668 | Rash (SNOMED) | active | 2024-06 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1146.671 | Fever (ICD10CM) | active | 2023-01 | us | hl7 | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1146.672 | Arthralgia (SNOMED) | active | 2023-01 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1146.673 | Arthralgia (ICD10CM) | active | 2023-06 | us | hl7 | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1146.674 | Conjunctivitis (SNOMED) | active | 2024-01 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1146.675 | Conjunctivitis (ICD10CM) | active | 2023-01 | us | hl7 | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1146.676 | Pregnant (SNOMED) | active | 2024-06 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1146.677 | Postpartum (SNOMED) | active | 2024-01 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1146.678 | Postpartum (ICD10CM) | active | 2023-01 | us | hl7 | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1146.679 | Hearing Loss (SNOMED) | active | 2025-02 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1146.680 | Abdominal Pain (ICD10CM) | active | 2023-06 | us | hl7 | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1146.681 | Abdominal Pain (SNOMED) | active | 2024-06 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1146.686 | Erythema Multiforme (SNOMED) | active | 2023-06 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1146.687 | Myalgia (ICD10CM) | active | 2023-01 | us | hl7 | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1146.689 | Periorbital Edema (ICD10CM) | active | 2023-01 | us | hl7 | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1146.691 | Eosinophilia (ICD10CM) | active | 2023-01 | us | hl7 | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1146.692 | Eosinophilia (SNOMED) | active | 2023-01 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1146.70 | Salmonellosis (Tests for Salmonella except S. typhi and S. paratyphi by Culture and Identification Method) | active | 2024-06 | us | hl7 | loinc | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1146.702 | Weight Loss (SNOMED) | active | 2024-06 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1146.705 | Syphilis (Tests for Treponemal or Non Treponemal Antibody) | active | 2025-02 | us | hl7 | loinc | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1146.709 | Cough [Non Productive] (SNOMED) | active | 2023-01 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1146.71 | Salmonellosis (Tests for Salmonella except S. typhi and S. paratyphi Nucleic Acid) | active | 2024-06 | us | hl7 | loinc | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1146.711 | Wound Infection (SNOMED) | active | 2024-01 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1146.712 | Pneumonia (ICD10CM) | active | 2024-01 | us | hl7 | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1146.713 | Sepsis [Septicemia] [Unspecified Organism] (ICD10CM) | active | 2023-01 | us | hl7 | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1146.714 | Sepsis [Septicemia] [Unspecified Organism] (SNOMED) | active | 2025-02 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1146.715 | Meningitis (SNOMED) | active | 2023-06 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1146.717 | Cellulitis (ICD10CM) | active | 2023-01 | us | hl7 | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1146.718 | Cellulitis (SNOMED) | active | 2025-02 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1146.719 | Myositis [Unspecified Cause] (SNOMED) | active | 2023-06 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1146.720 | Myositis [Unspecified Cause] (ICD10CM) | active | 2023-01 | us | hl7 | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1146.721 | Otitis Media (SNOMED) | active | 2025-02 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1146.722 | Otitis Media (ICD10CM) | active | 2023-01 | us | hl7 | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1146.723 | Otitis Externa (SNOMED) | active | 2025-02 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1146.724 | Otitis Externa (ICD10CM) | active | 2023-01 | us | hl7 | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1146.727 | Acute Upper Respiratory Illness (SNOMED) | active | 2023-06 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1146.728 | HIV Infection (Tests for HIV Nucleic Acid [Qualitative]) | active | 2023-06 | us | hl7 | loinc | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1146.730 | HIV Infection (Tests for HIV Antibody) | active | 2023-06 | us | hl7 | loinc | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1146.733 | Perinatal Hepatitis B Virus Infection (Disorders) (SNOMED) | active | 2023-06 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1146.744 | Coccidioidomycosis (Tests for Coccidioides species IgG Antibody) | active | 2024-01 | us | hl7 | loinc | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1146.746 | Treponema pallidum (Tests by Microscopic Observation) | active | 2022-01 | us | hl7 | loinc | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1146.750 | Chest Pain (SNOMED) | active | 2024-06 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1146.755 | Acute Upper Respiratory Illness (ICD10CM) | active | 2024-06 | us | hl7 | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1146.756 | Purpura (ICD10CM) | active | 2023-01 | us | hl7 | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1146.757 | Muscle Spasms (ICD10CM) | active | 2024-01 | us | hl7 | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1146.758 | Muscle Spasms (SNOMED) | active | 2023-01 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1146.762 | Mumps (Test Panels for mumps virus IgM IgG Antibody) | active | 2025-02 | us | hl7 | loinc | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1146.763 | Parotitis [Unspecified Cause] (SNOMED) | active | 2024-01 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1146.764 | Mumps (Tests for mumps virus IgG Antibody) | active | 2024-01 | us | hl7 | loinc | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1146.765 | Aseptic Meningitis (Disorders) (SNOMED) | active | 2025-02 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1146.766 | Encephalitis (Disorders) (SNOMED) | active | 2023-06 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1146.767 | Hearing Loss (ICD10CM) | active | 2023-01 | us | hl7 | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1146.770 | Invasive Pneumococcal Disease (Tests for Streptococcus pneumoniae Nucleic Acid in Specimen from Normally Sterile Site) | active | 2023-06 | us | hl7 | loinc | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1146.773 | Invasive Haemophilus influenzae Disease (Tests for Haemophilus influenzae Nucleic Acid in Specimen from Normally Sterile Site) | active | 2024-06 | us | hl7 | loinc | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1146.777 | Mastitis (SNOMED) | active | 2023-06 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1146.779 | Pancreatitis (SNOMED) | active | 2025-02 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1146.780 | Pancreatitis (ICD10CM) | active | 2023-01 | us | hl7 | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1146.782 | Rubella (Test Panels for rubella virus IgM IgG Antibody) | active | 2024-01 | us | hl7 | loinc | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1146.785 | Opioid Overdose and Poisoning (Tests for Opioids [Qualitative]) | active | 2025-02 | us | hl7 | loinc | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1146.789 | Purpura (SNOMED) | active | 2024-01 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1146.79 | Campylobacteriosis (Disorders) (SNOMED) | active | 2023-06 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1146.792 | Novel Influenza A Virus Infection (Disorders) (ICD10CM) | active | 2023-01 | us | hl7 | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1146.793 | Novel Influenza A Virus Infection (Disorders) (SNOMED) | active | 2024-01 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1146.794 | Sore Throat (SNOMED) | active | 2023-01 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1146.795 | Influenza (influenza A virus in Lab Results) | active | 2025-02 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1146.796 | Influenza (Novel influenza A virus in Lab Results) | active | 2024-01 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1146.797 | Influenza (Tests for influenza A or B virus by Culture and Identification Method) | active | 2023-01 | us | hl7 | loinc | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1146.798 | Influenza (Tests for influenza A virus Nucleic Acid) | active | 2025-02 | us | hl7 | loinc | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1146.799 | Influenza (Tests for influenza A virus Antigen) | active | 2023-01 | us | hl7 | loinc | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1146.802 | Influenza (Tests for Novel influenza A virus Nucleic Acid) | active | 2024-01 | us | hl7 | loinc | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1146.803 | Tests by Microscopic Observation in Tissue by H&E or PAS Stain | active | 2024-01 | us | hl7 | loinc | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1146.808 | Headache (ICD10CM) | active | 2023-06 | us | hl7 | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1146.809 | Headache (SNOMED) | active | 2024-01 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1146.810 | Backache (SNOMED) | active | 2023-06 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1146.811 | Backache (ICD10CM) | active | 2024-06 | us | hl7 | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1146.815 | NU_Anaplasmosis (Tests for Anaplasma species Antibody [Qualitative]) | active | 2023-06 | us | hl7 | loinc | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1146.816 | Rubella (Tests for rubella virus IgG Antibody [Ratio] in Serum) | active | 2024-01 | us | hl7 | loinc | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1146.818 | Measles (Tests for measles virus IgG Antibody [Ratio] in Serum) | active | 2025-03 | us | hl7 | loinc | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1146.820 | Rubella (Tests for rubella virus IgG Antibody [Quantitative] in Serum) | active | 2024-01 | us | hl7 | loinc | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1146.822 | Pneumoconiosis (Unspecified) (ICD10CM) | active | 2023-06 | us | hl7 | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1146.823 | Pneumoconiosis (Unspecified) (SNOMED) | active | 2023-01 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1146.824 | Computerized Tomography of Chest (Imaging) | active | 2023-01 | us | hl7 | loinc | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1146.830 | Poliovirus Infection (Tests for Poliovirus Antibody Titer in Serum Specimen) | active | 2025-02 | us | hl7 | loinc | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1146.835 | Lead in Blood (Disorders) (ICD10CM) | active | 2023-01 | us | hl7 | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1146.836 | Lead in Blood (Disorders) (SNOMED) | active | 2023-01 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1146.839 | Acid Fast Bacilli (Organism or Substance in Lab Results) | active | 2023-01 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1146.841 | Tuberculosis (Interferon Gamma Release Assays) | active | 2024-01 | us | hl7 | loinc | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1146.842 | Tests by Microscopic Observation in Tissue | active | 2024-06 | us | hl7 | loinc | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1146.846 | SARS (Tests for SARS_CoV by Culture and Identification Method) | active | 2024-01 | us | hl7 | loinc | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1146.847 | SARS (Tests for SARS_CoV Nucleic Acid) | active | 2024-01 | us | hl7 | loinc | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1146.86 | Hemolytic Uremic Syndrome (HUS) (Disorders) (SNOMED) | active | 2025-02 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1146.864 | Nausea (SNOMED) | active | 2023-01 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1146.865 | Confusion (SNOMED) | active | 2023-06 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1146.867 | Dyspnea (SNOMED) | active | 2023-01 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1146.869 | Loss of Consciousness (SNOMED) | active | 2024-01 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1146.87 | Thrombotic Thrombocytopenic Purpura (TTP) (SNOMED) | active | 2024-01 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1146.875 | SARS (Organism or Substance in Lab Results) | active | 2024-01 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1146.878 | MERS (Tests for MERS_CoV Nucleic Acid) | active | 2023-01 | us | hl7 | loinc | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1146.88 | Hemolytic Uremic Syndrome (HUS) (Disorders) (ICD10CM) | active | 2024-06 | us | hl7 | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1146.881 | Difficulty Breathing (SNOMED) | active | 2023-06 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1146.884 | Tests by Microscopic Observation in Blood | active | 2025-02 | us | hl7 | loinc | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1146.889 | Hantavirus Infection (Tests for Hantavirus IgM IgG Total Antibody) | active | 2025-02 | us | hl7 | loinc | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1146.892 | Organisms (Tests by Microscopic Observation in Tissue by Acid Fast Stain) | active | 2024-06 | us | hl7 | loinc | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1146.895 | Rhinorrhea (SNOMED) | active | 2024-01 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1146.896 | Tests by Microscopic Observation in Blood Smear | active | 2023-01 | us | hl7 | loinc | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1146.897 | Dengue Virus Infection (Test Panels for dengue virus IgM IgG Antibody) | active | 2025-02 | us | hl7 | loinc | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1146.9 | Xray of Chest (Imaging) | active | 2024-06 | us | hl7 | loinc | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1146.90 | Cough (ICD10CM) | active | 2023-01 | us | hl7 | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1146.902 | Acute Renal Failure [Unspecified Cause] (ICD10CM) | active | 2024-06 | us | hl7 | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1146.907 | Arthritis [Unspecified Cause] (SNOMED) | active | 2025-02 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1146.91 | Cough (SNOMED) | active | 2023-06 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1146.910 | Epididymitis [Unspecified Cause] (SNOMED) | active | 2023-01 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1146.911 | Epididymitis [Unspecified Cause] (ICD10CM) | active | 2023-01 | us | hl7 | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1146.914 | Osteomyelitis [Unspecified Cause] (SNOMED) | active | 2024-06 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1146.915 | Osteomyelitis [Unspecified Cause] (ICD10CM) | active | 2023-01 | us | hl7 | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1146.918 | Spondylitis [Unspecified Cause] (SNOMED) | active | 2025-02 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1146.919 | Arthritis [Unspecified Cause] (ICD10CM) | active | 2023-06 | us | hl7 | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1146.92 | Thrombotic Thrombocytopenic Purpura (TTP) (ICD10CM) | active | 2023-01 | us | hl7 | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1146.927 | Thrombocytopenia [Unspecified Cause] (ICD10CM) | active | 2023-01 | us | hl7 | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1146.928 | Bleeding [Unspecified Cause] (SNOMED) | active | 2024-06 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1146.930 | ECG Abnormalities [Unspecified Cause] (SNOMED) | active | 2024-06 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1146.931 | Hematemesis [Unspecified Cause] (SNOMED) | active | 2024-01 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1146.932 | Hematemesis [Unspecified Cause] (ICD10CM) | active | 2024-01 | us | hl7 | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1146.934 | Hematuria [Unspecified Cause] (SNOMED) | active | 2024-01 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1146.935 | Hemoptysis (SNOMED) | active | 2024-01 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1146.937 | Gastrointestinal Hemorrhage [Unspecified Cause] (SNOMED) | active | 2024-06 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1146.942 | Petechiae [Non Traumatic] (SNOMED) | active | 2024-01 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1146.952 | Thrombocytopenia [Unspecified Cause] (SNOMED) | active | 2024-06 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1146.956 | Sepsis [Septicemia] [Bacterial] [Unspecified Organism] (SNOMED) | active | 2024-06 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1146.957 | Regional Lymphadenitis [Including Bubo] (SNOMED) | active | 2025-02 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1146.958 | Regional Lymphadenitis (ICD10CM) | active | 2023-06 | us | hl7 | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1146.965 | Proteinuria [Unspecified Cause] (ICD10CM) | active | 2023-06 | us | hl7 | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1146.969 | Proteinuria [Unspecified Cause] (SNOMED) | active | 2024-06 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1146.970 | Bulbar Weakness (SNOMED) | active | 2024-06 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1146.971 | Bulbar Weakness (ICD10CM) | active | 2024-06 | us | hl7 | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1146.976 | Dysphagia (SNOMED) | active | 2025-02 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1146.978 | Impaired Respiration [Unspecified Cause] (SNOMED) | active | 2024-06 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1146.979 | Botulism (Organism or Substance in Lab Results) | active | 2024-06 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1146.98 | Shigellosis (Disorders) (SNOMED) | active | 2024-01 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1146.989 | Tests for Mycobacterium species by Culture and Identification Method | active | 2025-02 | us | hl7 | loinc | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1146.994 | Organisms (Tests for Nucleic Acid) | active | 2023-01 | us | hl7 | loinc | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1146.998 | Shigellosis (Tests for Enteroinvasive E. coli Nucleic Acid) | active | 2025-02 | us | hl7 | loinc | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1146.999 | Chlamydia species (Organism or Substance in Lab Results) | active | 2023-06 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1147.109 | Pressure Injury Stage 2, 3, 4 or Unstageable | active | 2023-02 | us | hl7 | loinc | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1147.110 | Pressure Injury Stage 2, 3, 4 or Unstageable | active | 2024-01 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1147.112 | Pressure Injury Deep Tissue | active | 2024-01 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1147.113 | Pressure Injury Stage 2, 3, 4 or Unstageable | active | 2022-04 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1147.122 | Inpatient Falls | active | 2021-06 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1147.130 | Anticoagulants for VTE Prophylaxis | active | 2025-02 | us | hl7 | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1147.131 | Anticoagulants for Indications Other than VTE Prophylaxis | active | 2024-01 | us | hl7 | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1147.160 | Abdominal or Pelvic CT Scan with Contrast | active | 2024-06 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1147.163 | Ultrasound of Lower Extremities | active | 2024-08 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1147.164 | Ultrasound of Lower Extremities | active | 2024-08 | us | hl7 | loinc | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1147.165 | Ultrasound of Lower Extremities | active | 2024-08 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1147.171 | Inpatient Falls | active | 2021-06 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1147.183 | Anti Factor Xa Assay | active | 2024-06 | us | hl7 | loinc | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1147.187 | Extracorporeal Membrane Oxygenation (ECMO) | active | 2022-04 | us | hl7 | cms | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1147.188 | Extracorporeal Membrane Oxygenation (ECMO) | active | 2022-04 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1147.190 | Intra Aortic Balloon Pump | active | 2022-04 | us | hl7 | cms | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1147.191 | Intra Aortic Balloon Pump | active | 2022-04 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1147.193 | Resuscitative Endovascular Balloon Occlusion of the Aorta (REBOA) | active | 2022-04 | us | hl7 | cms | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1147.194 | Pressure Injury Deep Tissue Diagnoses | active | 2022-04 | us | hl7 | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1147.196 | Pressure Injury Stage 2, 3, 4, or Unstageable Diagnoses | active | 2022-04 | us | hl7 | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1147.197 | Present on Admission or Clinically Undetermined | active | 2022-04 | us | hl7 | cms | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1147.198 | Not Present On Admission or Documentation Insufficient to Determine | active | 2022-04 | us | hl7 | cms | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1151.1 | DEXA Dual Energy Xray Absorptiometry, Bone Density | active | 2016-07 | us | hl7 | cpt | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1151.11 | Bladder Cancer Staging Ta for Urology Care | active | 2016-07 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1151.12 | Bladder Cancer staging T1 for Urology Care | active | 2024-02 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1151.13 | Bladder Cancer staging Tis for Urology Care | active | 2024-02 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1151.15 | Carcinoma of urinary bladder, superficial | active | 2016-07 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1151.16 | Injection Leuprolide Acetate | active | 2017-08 | us | hl7 | cms | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1151.17 | High grade bladder cancer Ta for Urology Care | active | 2017-02 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1151.18 | Immunocompromised state for Urology Care | active | 2017-02 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1151.19 | Systemic chemotherapy for urology care | active | 2017-02 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1151.2 | Bladder Cancer in Situ | active | 2016-07 | us | hl7 | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1151.20 | Corticosteroids for patients receiving Urology Care | active | 2017-02 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1151.21 | Calcineurin inhibitors for patients receiving Urology Care | active | 2017-02 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1151.23 | Immunomodulators for patients undergoing Urology Care | active | 2017-02 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1151.24 | Monoclonal antibody for patient undergoing Urology Care | active | 2017-02 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1151.28 | Radiotherapy for patients undergoing Urology Care | active | 2017-02 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1151.29 | Plasmacytoid cell, morphologic abnormality for urology care | active | 2017-02 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1151.3 | Bladder Cancer in Situ | active | 2024-02 | us | hl7 | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1151.30 | Sarcomatoid, morphologic abnormality for Urology Care | active | 2017-02 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1151.31 | Micropapillary, morphologic abnormality, for Urology Care | active | 2017-02 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1151.32 | Immunosuppressive Drugs for Urology Care | active | 2024-02 | us | hl7 | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1151.38 | DEXA Dual Energy Xray Absorptiometry, Bone Density for Urology Care | active | 2017-08 | us | hl7 | loinc | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1151.39 | Mixed histology urothelial cell carcinoma for Urology Care | active | 2023-02 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1151.4 | BCG Bacillus Calmette Guerin, Tice | active | 2016-07 | us | hl7 | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1151.40 | Cystectomy for Urology Care | active | 2017-03 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1151.44 | Unavailability of Bacillus Calmette Guerin for urology care | active | 2017-03 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1151.45 | Bladder Cancer for Urology Care | active | 2017-03 | us | hl7 | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1151.48 | Androgen deprivation therapy for Urology Care | active | 2021-02 | us | hl7 | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1151.5 | BCG Bacillus Calmette Guerin, Connaught | active | 2016-07 | us | hl7 | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1151.52 | BCG Bacillus Calmette Guerin for Urology Care | active | 2020-02 | us | hl7 | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1151.53 | Cystectomy for Urology Care | active | 2018-04 | us | hl7 | cpt | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1151.54 | Acute Tuberculosis for Urology Care | active | 2018-04 | us | hl7 | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1151.55 | Cystectomy for Urology Care | active | 2022-03 | us | hl7 | vsac |